Method for engineered geothermal system treatment using brines
US-2024352305-A1 · Oct 24, 2024 · US
US9869156B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9869156-B2 |
| Application number | US-201314380281-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 22, 2013 |
| Priority date | Oct 22, 2013 |
| Publication date | Jan 16, 2018 |
| Grant date | Jan 16, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Clay-based retarders may be useful in delaying the gel time of a gellable treatment fluid and, consequently, subterranean operations. For example, a method may involve providing a gellable treatment fluid comprising: an aqueous base fluid; a base polymer comprising an acrylamide monomer unit; a polymeric organic crosslinking agent comprising a crosslinkable polymer selected from the group consisting of polyethyleneimine, polyvinylamine, chitosan, any derivative thereof, any salt thereof, and any combination thereof; and a clay-based gel retarder; introducing the gellable treatment fluid into a wellbore penetrating a subterranean formation; and forming a gel with the gellable treatment fluid in at least a portion of the wellbore, at least a portion of the subterranean formation, or both. In some instances, producing the gellable treatment fluid may involve not pre-hydrating the clay-based gel retarder. In some instances, the gellable treatment fluid may not be thixotropic or pseudoplastic before introduction into the wellbore.
Opening claim text (preview).
The invention claimed is: 1. A method comprising: providing a gellable treatment fluid comprising: an aqueous base fluid; a base polymer; a polymeric organic crosslinking agent comprising a crosslinkable polymer; and a clay-based gel retarder comprising a plurality of clay platelets, wherein the platelets have at least one surface that has been treated with a surface activity modifier that comprises one selected from the group consisting of sodium silicate, an alkaline lignosulfate, an amino alkylene phosphonate, propylene carbonate, and any combination thereof, wherein the clay-based gel retarder comprises at least one selected from the group consisting of a laponite, a modified laponite, and combination thereof, wherein the clay-based gel retarder is used in aggregate, not pre-hydrated, form and wherein the base polymer comprises a copolymer of acrylamide and t-butyl acrylate and the crosslinkable polymer is polyethyleneimine; introducing the gellable treatment fluid into a wellbore penetrating a subterranean formation; and forming a gel with the gellable treatment fluid in at least a portion of the wellbore, at least a portion of the subterranean formation, or both. 2. The method of claim 1 , wherein providing the gellable treatment fluid involves concurrently combining the aqueous base fluid, the base polymer, the polymeric organic crosslinking agent, and a dry form of the clay-based gel retarder. 3. The method of claim 1 , wherein the clay-based gel retarder comprises a plurality of clay platelets having an average diameter of about 10 nm to about 100 nm and an average thickness of about 0.5 nm to about 2 nm. 4. The method of claim 1 , wherein the clay-based gel retarder comprises aggregates of a plurality of clay platelets having an average diameter of about 100 nm to about 2000 nm. 5. The method of claim 1 , wherein the gellable treatment fluid further comprises a clay-activator. 6. The method of claim 1 , wherein the clay-based gel retarder is present in the gellable treatment fluid in an amount of about 0.1% to about 15% by weight of the aqueous base fluid. 7. The method of claim 1 , wherein the base polymer is present in the gellable treatment fluid in an amount of about 0.1% to about 10% by weight of the aqueous base fluid. 8. The method of claim 1 , wherein the polymeric organic crosslinking agent is present in the gellable treatment fluid in an amount of about 0.1% to about 5% by weight of the aqueous base fluid. 9. The method of claim 1 , wherein the base polymer and the polymeric organic crosslinking agent are at a relative weight ratio of about 1:2 to about 50:1. 10. The method of claim 1 further comprising: infiltrating a porous matrix of the subterranean formation with at least a portion of the gellable treatment fluid; and forming the gel in at least a portion of the porous matrix of the subterranean formation with the gellable treatment fluid. 11. The method of claim 1 , wherein forming the gel is in an annulus within the wellbore. 12. The method of claim 1 , wherein forming the gel is in a gravel pack, and wherein the clay-based gel retarder comprises a plurality of clay platelets having an average diameter of about 10 nm to about 100 nm and an average thickness of about 0.5 nm to about 2 nm. 13. A system comprising: a pump fluidly coupled to a tubular that penetrates a subterranean formation, wherein the tubular contains a gellable treatment fluid that comprises an aqueous base fluid; a base polymer; a polymeric organic crosslinking agent comprising a crosslinkable polymer; and a clay-based gel retarder comprising a plurality of clay platelets, wherein the platelets have at least one surface that has been treated with a surface activity modifier that comprises one selected from the group consisting of sodium silicate, an alkaline lignosulfate, an amino alkylene phosphonate, propylene carbonate, and any combination thereof; wherein the clay-based gel retarder comprises at least one selected from the group consisting of a laponite, a modified laponite, and combination thereof, wherein the clay-based gel retarder is used in aggregate, not pre-hydrated, form and wherein the base polymer comprises a copolymer of acrylamide and t-butyl acrylate and the crosslinkable polymer is polyethyleneimine. 14. A method comprising: providing a gellable treatment fluid comprising: an aqueous base fluid; a base polymer; a polymeric organic crosslinking agent comprising a crosslinkable polymer; and a clay-based gel retarder that comprises a plurality of clay platelets having an average diameter of about 10 nm to about 100 nm and an average thickness of about 0.5 nm to about 2 nm and, wherein the platelets have at least one surface that has been treated with a surface activity modifier that comprises one selected from the group consisting of sodium silicate, an alkaline lignosulfate, an amino alkylene phosphonate, propylene carbonate, and any combination thereof; wherein the clay-based gel retarder comprises at least one selected from the group consisting of a laponite, a modified laponite, and combination thereof, wherein the clay-based gel retarder is used in aggregate, not pre-hydrated, form and wherein the base polymer comprises a copolymer of acrylamide and t-butyl acrylate and the crosslinkable polymer is polyethyleneimine; introducing the gellable treatment fluid into a wellbore penetrating a subterranean formation, the subterranean formation comprising a porous matrix; infiltrating at least a portion of the porous matrix of the subterranean formation with the gellable treatment fluid; and forming a gel in the porous matrix of the subterranean formation with the gellable treatment fluid. 15. A method comprising: providing a gellable treatment fluid by concurrently combining an aqueous base fluid, a base polymer, a polymeric organic crosslinking agent comprising a crosslinkable polymer, and a dry form of a clay-based gel retarder, wherein the clay-based gel retarder comprises (1) at least one selected from the group consisting of a laponite, a modified laponite, a natural hectorite, a montmorillonite, a sapiolite, and any combination thereof and (2) a plurality of clay platelets, wherein the platelets have at least one surface that has been treated with a surface activity modifier that comprises one selected from the group consisting of sodium silicate, an alkaline lignosulfate, an amino alkylene phosphonate, propylene carbonate, and any combination thereof; wherein the clay-based gel retarder comprises at least one selected from the group consisting of a laponite, a modified laponite, and combination thereof, wherein the clay-based gel retarder is used in aggregate, not pre-hydrated, form and wherein the base polymer comprises a copolymer of acrylamide and t-butyl acrylate and the crosslinkable polymer is polyethyleneimine; introducing the gellable treatment fluid into a wellbore penetrating a subterranean formation; and forming a gel with the gellable treatment fluid in at least a portion of the wellbore, at least a portion of the subterranean formation, or both.
Nanoparticle-containing well treatment fluids · CPC title
Polymers · CPC title
Gravelling of wells · CPC title
Plastering the borehole wall; Injecting into the formation · CPC title
Enhanced recovery methods for obtaining hydrocarbons · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.